Can cancer patients stop bone drugs safely after years?
NCT ID NCT04549207
Summary
This study aims to find out if patients with bone metastases from breast or prostate cancer can safely reduce or stop their bone-strengthening medications after taking them for over two years. It will compare continuing the drugs versus lowering the dose or stopping them, focusing on quality of life and bone complications. The goal is to see if treatment can be simplified for patients who are stable.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
London Health Sciences Centre
London, Ontario, N6A 5W9, Canada
-
Southlake Regional Health Centre
Newmarket, Ontario, L3Y 2P9, Canada
-
The Ottawa Hospital Cancer Centre
Ottawa, Ontario, Canada
-
Thunder Bay Regional Health Sciences Centre
Thunder Bay, Ontario, P7B 6V4, Canada
-
William Osler Health System
Brampton, Ontario, L6R 3J7, Canada
Conditions
Explore the condition pages connected to this study.